FDA Clears Magstim TMS Horizon 3.0 with StimGuide Pro Treatment for Patients with Depression, Obsessive Compulsive Disorder, Anxious Depression
FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro
January 30, 2024 09:18 ET | Magstim EGI
FDA clears Magstim TMS System Horizon 3.0 with StimGuide Pro providing treatment for patients patients with depressive or obsessive-compulsive conditions
22157.jpg
United Kingdom Mental Health Apps Market Size, Share & Trends Analysis Report 2023-2030 Featuring Mindspace, Calm, Headspace, Youper, MoodMission, and Sanvello Health
January 24, 2024 10:27 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "U.K. Mental Health Apps Market Size, Share & Trends Analysis Report By Platform (Android, iOS), By Application (Depression & Anxiety...
MindFit Toolkit - Mental Wellness for Men by Canadian Men's Health Foundation
Canadian Men’s Health Foundation reports that more men are addressing stress, anxiety and depression
January 18, 2024 08:00 ET | Canadian Men's Health Foundation
CMHF is helping more men tackle chronic stress, anxiety and depression with the MindFit Toolkit, presented by TELUS Health.
Lifeist.png
Mikra Launches New Immune Protect Gummies with Bundle Sales Promotion
December 20, 2023 07:00 ET | Lifeist Wellness Inc.
Mikra launches Protect, a new natural immune support product based on Aronia berries and key vitamins, shipping a free trial bottle with our next 500 order
Lifeist.png
Mikra to Introduce Innovative Immune Support Gummy
December 14, 2023 07:00 ET | Lifeist Wellness Inc.
Mikra introduces PROTECT, a new natural immune support product based on Aronia berries and key vitamins
Mikra Serenity
Clinical Research Shows the Active Ingredient in Mikra’s Serenity Matches a Benzodiazepine in Effectiveness at Fighting Anxiety, Without Being Habit-Forming
December 06, 2023 07:00 ET | Lifeist Wellness Inc.
TORONTO, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)
December 01, 2023 09:00 ET | Cingulate Inc.
KANSAS CITY, Kan., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Lifeist Wellness
Mikra Successfully Launches Serenity, an Innovative Mental Health Product for Anxiety
November 30, 2023 07:00 ET | Lifeist Wellness Inc.
TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Mikra Serenity GCMS Verified Dietary Supplement for the Relief of Anxiety
Mikra Receives First Shipment of Serenity, an Innovative Mental Health Product for Anxiety, in Time for Black Friday
November 22, 2023 07:00 ET | Lifeist Wellness Inc.
TORONTO, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Helping Children and
Helping Children and Adolescents with Emotional Problems: Free Webinar for Parents and Educators from the Brain & Behavior Research Foundation
November 16, 2023 13:00 ET | Brain & Behavior Research Foundation
New York, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Children’s mental health is a major concern and improving the potential for early intervention is essential. The Brain & Behavior Research Foundation...